Evaluation of the knowledge, attitude and the practice of pharmacovigilance among the interns and doctors in a tertiary level care teaching hospital in Northern India

Manreet Singh Sekhon, Anita K. Gupta, Neetu Sharma


Background: Adverse drug reaction (ADR) is defined by world health organization (WHO) as “a response to a drug, which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease or for the modification of physiological function. The objective of this study was investigating the knowledge, attitudes and practices of doctors and interns to ADR reporting and reasons for underreporting of ADRs.

Methods: It was a questionnaire-based, cross-sectional study. Questionnaires was designed, validated by doing a pilot study, administered to doctors and interns working in a teaching hospital with an ADR monitoring center. This questionnaire was administered to randomly select 500 faculty members, interns and the resident doctors for inclusion in the study, out of which only 209 responded. The study was approved by institutional ethics committee, government medical college Patiala. Only those who gave their consent to participate were included in the study. The data was analysed by using the statistical package for social sciences (SPSS) statistical software, version 20.

Results: Only 20 % faculty members and 51% interns were aware of AMC in our institute. Legal inquiry/action involved for reporting an ADR was the main worry while reporting an ADR for faculty member (68%). Lack of time to report ADR was the main reason given by Interns (22%) and not knowing to whom and where to report was the main reason given by Interns PGs (40%). Awareness of postgraduate residents (90%) was overall better than faculty and interns.

Conclusions: There is a great need to create awareness and to promote the reporting of ADR amongst interns and doctors, which will lay a solid foundation for these healthcare professionals to be involved in quality pharmacovigilance.


Pharmacovigilance, ADR reporting, Doctors

Full Text:



International drug monitoring: The role of National Centres. Report No: 498. Geneva, Switzerland: World Health Organization; World Health Organization; 1972.

Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18820 patients. Br Med J. 2004;329:15-9.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA. 1998;279:1200-5.

The importance of pharmacovigilance. Safety monitoring of medicinal products. Geneva: World Health Organization; World Health Organization Collaborating Centre for International Drug Monitoring; 2002.

Pharmacovigilance programme of India 2010. CDSCO, Ministry of Health and Family Welfare, Government of India; 2010.

Wysowsky DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: The importance of reporting suspected reactions. Arch Intern Med. 2005;165:1363-9.

Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: A systematic review. Drug Saf. 2009;32:19-31.

Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J ClinPharmacol. 1996;42:423-42.

Feely J, Moriarty S, O’Connor P. Stimulating reporting of adverse drug reaction by using a fee. Br Med J. 1990;300:22-3.

Inman WH. Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol. 1996;41:433-5.

World Health Organization. Safety of medicines. A Guide to Detecting and Reporting Adverse Drug Reactions. Geneva, Switzerland: World Health Organization; 2002.

Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol. 1998;45:301‐8.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors. J Pharm Sci Res. 2011;3:1064‐9.

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2:129‐36.

Bateman DN, Sanders GL, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol. 1992;34:421‐6.

Milstein JB, Faich GA, Hsu JP. Factors affecting physician reporting of adverse drug reactions. Drug Inf J. 1986;20:157‐64.

Madhan R, Parthasarathi G. Adverse drug reactions reporting: attitudes and perceptions of medical practitioners. Asian J Pharm Clin Res. 2009;2:10‐4.

Hazell L, Shakir SA. Under‐reporting of adverse drug reactions: A systematic review. Drug Saf. 2006;29:385‐96.